ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,000 | -25.5% | 31,264 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | -19.1% | 31,264 | 0.0% | 0.00% | – |
| Q3 2021 | $68,000 | -37.6% | 31,264 | 0.0% | 0.00% | – |
| Q2 2021 | $109,000 | -64.6% | 31,264 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $308,000 | -9.1% | 31,264 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $339,000 | +5.3% | 31,264 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $322,000 | -50.7% | 31,264 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $653,000 | +183.9% | 31,264 | +32.7% | 0.00% | +100.0% |
| Q1 2020 | $230,000 | +0.9% | 23,560 | +19.3% | 0.00% | 0.0% |
| Q4 2019 | $228,000 | +111.1% | 19,750 | 0.0% | 0.00% | – |
| Q3 2019 | $108,000 | -54.0% | 19,750 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $235,000 | +183.1% | 19,750 | +24.4% | 0.00% | – |
| Q1 2019 | $83,000 | +66.0% | 15,880 | 0.0% | 0.00% | – |
| Q4 2018 | $50,000 | -47.9% | 15,880 | 0.0% | 0.00% | – |
| Q3 2018 | $96,000 | +14.3% | 15,880 | 0.0% | 0.00% | – |
| Q2 2018 | $84,000 | – | 15,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |